Response to: 'Correspondence on 'EULAR definition of difficult-to-treat rheumatoid arthritis'' by Novella-Navarro
et al
Ann Rheum Dis
.
2023 Mar;82(3):e56.
doi: 10.1136/annrheumdis-2020-219535.
Epub 2020 Dec 4.
Authors
Nadia M T Roodenrijs
1
,
Paco M J Welsing
2
,
Marlies C van der Goes
2
3
,
Johannes Wg Jacobs
2
,
Désirée van der Heijde
4
,
Jacob M van Laar
2
,
György Nagy
5
Affiliations
1
Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht, Utrecht, The Netherlands N.M.T.Roodenrijs@umcutrecht.nl.
2
Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht, Utrecht, The Netherlands.
3
Rheumatology, Meander Medical Center, Amersfoort, The Netherlands.
4
Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.
5
Genetics, Cell- and Immunobiology & Rheumatology and Clinical Immunology, Semmelweis University, Budapest, Hungary.
PMID:
33277239
DOI:
10.1136/annrheumdis-2020-219535
No abstract available
Keywords:
arthritis; inflammation; rheumatoid.
Publication types
Comment
MeSH terms
Antirheumatic Agents* / therapeutic use
Arthritis, Rheumatoid* / drug therapy
Humans
Substances
Antirheumatic Agents